FDA Warns Patients and Health Care Providers About Potential Risks Associated With Compounded Ketamine Products

FDA Warns Patients and Health Care Providers About Potential Risks Associated With Compounded Ketamine Products

Audience: Patients, Health Care Providers There is increased interest in compounded ketamine products (including oral formulations) for the treatment of…

Read More »